1. Synthesis of the antileukemic agents 5,10-dideazaaminopterin and 5,10-dideaza-5,6,7,8-tetrahydroaminopterin;Taylor;J. Med. Chem.,1985
2. The in vivo activity of 5,10-dideazatetrahydrofolic acid (DDATHF) and its diastereomers;Shih;Proc. Am. Assoc. Cancer Res.,1988
3. A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis;Beardsley;J. Biol. Chem.,1989
4. A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors;Habeck;Cancer Res.,1994
5. Biological properties of AG2034: a new inhibitor of glycinamide ribonucleotide formyltransferase;Boritzki;Proc. Am. Assoc. Cancer Res.,1996